Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
HungaryStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
HungaryLong-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks
HungaryStudy on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy
HungaryLong-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia
HungaryStudy on the Effects of Somapacitan and Somatropin in Children with Short Stature Born Small for Gestational Age Without Catch-Up Growth by Age 2
HungaryStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
HungaryStudy on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
HungaryStudy on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury
HungaryStudy on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction
HungaryStudy on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.
